bg
R

Relmada Therapeutics (RLMD)

$000.00 0.00% ($0.00)

  • اليوم
  • الأسبوع
  • الشهر
  • السنة
  • ٥ سنوات
  • حتى اليوم
barakagetbaraka.com

عن Relmada Therapeutics (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... اقرأ أكثر

  • USD2.21
  • USD2.81
  • USD2.19
  • USD3.50
  • 19.40%
  • --
  • 45.68k
  • 291.87k
  • 75M
  • 0.24
  • -19.00%

أخبار الأسهم